This announcement is a separate document:
海通证券股份有限公司关于重庆智翔金泰生物制药股份有限公司首次公开发行部分限售股上市流通的核查意见
Inspection opinions of Haitong Securities Co., Ltd. on the initial public offering of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. and the listing circulation of some restricted shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.